Hainan Huluwa Pharmaceutical Group Co., Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was CNY 1,161.705 million compared to CNY 1,305.918 million a year ago. Operating income was CNY 134.172 million compared to CNY 141.551 million a year ago. Net income was CNY 121.502 million compared to CNY 120.329 million a year ago. Basic earnings per share from continuing operations was CNY 0.32 compared to CNY 0.33 a year ago.